Tocopherol transfer protein deficiency modifies nuclear receptor transcriptional networks in lungs: modulation by

K Gohil1, S Oommen, V T Vasu

  • 1Pulmonary and Critical Care Medicine, Genome and Biomedical Sciences Facility, 451 East Health Sciences Drive, University of California, Davis, CA 95616, USA. kgohil@ucdavis.edu

Insights

This study shows alpha-tocopherol (AT) concentration in the lungs modulates gene expression in response to cigarette smoke (CS). AT deficiency exacerbates CS-induced AhR activation but not Nrf2 activation, impacting immune gene responses.

Area of Science:

  • Environmental Health
  • Toxicology
  • Molecular Biology

Background:

  • Dietary factors and environmental pollutants influence organism health via transcription factor networks like AhR, Nrf2, and NF-kappaB.
  • Reactive oxygen metabolites (ROMs) are hypothesized mediators, with alpha-tocopherol (AT) acting as a potent antioxidant.
  • The lung is a critical organ for studying AT's in vivo effects, with lung AT levels manipulable via diet and genetics.

Purpose of the Study:

  • To investigate the role of lung alpha-tocopherol (AT) concentration in modulating gene expression in response to cigarette smoke (CS).
  • To test the hypothesis that AT modulates transcription factor networks (AhR, Nrf2, NF-kappaB) in the lung during environmental pollutant exposure.

Main Methods:

  • Utilized alpha-tocopherol transfer protein-deficient (ATTP-KO) mice, which exhibit severe AT deficiency, and their wild-type (WT) counterparts.
  • Exposed mice to either air or cigarette smoke (CS) for 3 or 10 days.
  • Performed genome-wide GeneChip analysis on lung tissue to assess differential gene expression modulated by CS and lung AT concentration.

Main Results:

  • Cigarette smoke (CS) activated AhR-driven genes (e.g., cyp1b1), with induction augmented in AT-deficient lungs.
  • CS-induced expression of some Nrf2-driven genes was not potentiated in AT-deficient lungs.
  • CS repressed lymphocyte and leukocyte-specific genes (including cytokines and immunoglobulins), with modulation by lung AT concentration.

Conclusions:

  • Lung AT concentration modulates the expression of xenobiotic and immune response genes in response to CS exposure.
  • Data suggest a network involving AT, its metabolites, and ATTP influences gene transcription regulated by AhR, Nrf2, and NF-kappaB.
  • These findings highlight AT's role in orchestrating lung adaptive responses to inhaled environmental pollutants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...